Company news

Solventum Corporation news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Solventum Announces FDA 510(k) Clearance for Combined Use of Restrata™ Matrix and Solventum™ V.A.C.® Therapy*

October 19, 2026

Solventum to Report Third Quarter Fiscal 2026 Earnings on November 5, 2026

October 15, 2026

Solventum to Participate in the 2026 Wells Fargo Healthcare Conference

September 2, 2026

Solventum Reports Second Quarter 2026 Financial Results

August 5, 2026

Solventum Announces Intent to Separate its Health Information Systems Business

August 5, 2026

Solventum to Report Second Quarter Fiscal 2026 Earnings on August 5, 2026

July 15, 2026

Solventum to Participate in the 2026 Jefferies Healthcare Conference

May 27, 2026

Solventum to Participate in the 2026 BofA Securities Health Care Conference

May 7, 2026

Solventum Reports First Quarter 2026 Financial Results

May 5, 2026

Solventum to Report First Quarter Fiscal 2026 Earnings on May 5, 2026

April 14, 2026

Solventum to Participate in the 2026 KeyBanc Healthcare Forum

March 11, 2026

Solventum Reports Fourth Quarter 2025 Financial Results and Introduces 2026 Full-Year Guidance

February 26, 2026

Solventum to Report Fourth Quarter and Full Year Fiscal 2025 Earnings on February 26, 2026

February 3, 2026

Solventum Completes Acquisition of Acera Surgical

December 23, 2025

Global Expert Panel Publishes New Recommendations on Advanced Use of Closed Incision Negative Pressure Therapy

December 17, 2025

Solventum Earns Diamond Level HIRC Resiliency Badge, Demonstrating Best-In-Class Supply Chain Strength

December 16, 2025

Solventum to Participate in the 2025 Piper Sandler Healthcare Conference

November 25, 2025

Solventum Announces Agreement to Acquire Acera Surgical

November 20, 2025

Solventum Announces $1 Billion Share Repurchase Program

November 20, 2025

Solventum Reports Third Quarter 2025 Financial Results

November 6, 2025

Solventum to Participate in the 2025 Stifel Healthcare Conference

November 3, 2025

Solventum Appoints Heather Knight as Chief Commercial Officer

October 21, 2025

Solventum to Report Third Quarter Fiscal 2025 Earnings on November 6, 2025

October 16, 2025

Solventum Announces Pricing of its Upsized $2 Billion Note Tender Offers

September 8, 2025

Solventum Announces Early Tender Results and Upsizing of its Note Tender Offers

September 8, 2025

Solventum Completes Sale of its Purification & Filtration Business to Thermo Fisher Scientific Inc.

September 2, 2025

Solventum to Participate in Upcoming Investor Conferences

August 28, 2025

Solventum Announces $1.75 Billion Note Tender Offers

August 22, 2025

Solventum Announces Pricing of Secondary Offering of Common Stock

August 13, 2025

Solventum Announces Launch of Secondary Offering of Common Stock

August 13, 2025

Solventum Reports Second Quarter 2025 Financial Results

August 7, 2025

Solventum to Report Second Quarter Fiscal 2025 Earnings on August 7, 2025

July 17, 2025

Solventum Named a Best Company to Work for by U.S. News & World Report

June 18, 2025

Solventum to Participate in the 2025 Goldman Sachs Health Care Conference

June 3, 2025

Solventum Reports First Quarter 2025 Financial Results

May 8, 2025

Solventum to Participate in the 2025 BofA Securities Health Care Conference

May 8, 2025

Solventum to Report First Quarter Fiscal 2025 Earnings on May 8, 2025

April 17, 2025

Solventum partners with SprintRay to disrupt the digital dentistry market with high-quality, permanent same-day restorations

March 25, 2025

Solventum to Present Value Creation Formula and Long-Range Plan at 2025 Investor Day

March 20, 2025

Solventum Launches Attest™ eBowie-Dick Test System Revolutionizing Sterilization Assurance

March 12, 2025

Solventum Reports Fourth Quarter 2024 Financial Results and Introduces 2025 Full-Year Guidance

February 27, 2025

Solventum to Host Investor Day on Thursday, March 20, 2025, in New York City

February 26, 2025

Solventum Announces Sale of its Purification & Filtration Business to Thermo Fisher Scientific Inc. for $4.1B

February 25, 2025

Calls

The 5 newest of 9 calls. Every call is listed under its year.

Decks

The 5 newest of 15 decks. Every deck is listed under its year.